Pulmonary Medicine

1-14 of 14

CME/CE Virtual Event
Closing the Gap in First-Line Treatment of KRAS G12C–Mutated Advanced NSCLC: From Biology to Bedside Decisions and Trial-Ready Care
November 9, 2026
0.75 credits
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
CME/CE
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
Robert D. Suh, MD; Lea Azour, MD
1.00 credit
- Robert D. Suh, MD
- Lea Azour, MD
- Ashwin Basavaraj, MD
1.00 credit
The Safety of Sodium Oxybate in Treating Narcolepsy
The Safety of Sodium Oxybate in Treating Narcolepsy
CME/CE
The Safety of Sodium Oxybate in Treating Narcolepsy
Clete A. Kushida, MD, PhD; Sally Ibrahim, MD, FAAP
0.50 credits
- Clete A. Kushida, MD, PhD
- Sally Ibrahim, MD, FAAP
0.50 credits
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
CME/CE
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
Jonathan Leventhal, MD; Shahnaz Singh-Kandah, NP
0.25 credits
- Jonathan Leventhal, MD
- Shahnaz Singh-Kandah, NP
0.25 credits
Advances in Minimally Invasive Screening for Lung Cancer
Advances in Minimally Invasive Screening for Lung Cancer
CME/CE
Advances in Minimally Invasive Screening for Lung Cancer
Julie A. Barta, MD, ATSF; Peter J. Mazzone, MD, MPH, FCCP
0.25 credits
- Julie A. Barta, MD, ATSF
- Peter J. Mazzone, MD, MPH, FCCP
0.25 credits
The Real Cost of Smoking: Medical, Financial, and Societal Considerations
The Real Cost of Smoking: Medical, Financial, and Societal Considerations
Primary Care Today
The Real Cost of Smoking: Medical, Financial, and Societal Considerations
Brian P. McDonough, MD, FAAFP
- Brian P. McDonough, MD, FAAFP
FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
FDA Drug Information Updates
FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
Q&A with Penn Medicine Experts: Hot Topics in Primary Care
Q&A with Penn Medicine Experts: Hot Topics in Primary Care
Medical Breakthroughs from Penn Medicine
Q&A with Penn Medicine Experts: Hot Topics in Primary Care
Robert H. Debbs, DO; Ari Brooks, MD
- Robert H. Debbs, DO
- Ari Brooks, MD
- Paris D. Butler, MD, MPH
- Patrick J. Connolly, MD
- Taine Pechet, MD
- Brian Englander, MD
A Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung Cancer Patient
A Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung Cancer Patient
Medical Breakthroughs from Penn Medicine
A Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung Cancer Patient
Matt Birnholz, MD; Taine Pechet, MD
- Matt Birnholz, MD
- Taine Pechet, MD
Cell Death and Differentiation: A Novel Treatment of Cystic Fibrosis Acting On-Target
Cell Death and Differentiation: A Novel Treatment of Cystic Fibrosis Acting On-Target
AudioAbstracts
Cell Death and Differentiation: A Novel Treatment of Cystic Fibrosis Acting On-Target
Journal of Cystic Fibrosis: Microbial Colonization and Lung Function in Adolescents With Cystic Fibrosis
Journal of Cystic Fibrosis: Microbial Colonization and Lung Function in Adolescents With Cystic Fibrosis
AudioAbstracts
Journal of Cystic Fibrosis: Microbial Colonization and Lung Function in Adolescents With Cystic Fibrosis
Journal of Cystic Fibrosis: Efficacy and Safety of Levofloxacin Inhalation Solution (APT-1026) in Stable Cystic Fibrosis Patients
Journal of Cystic Fibrosis: Efficacy and Safety of Levofloxacin Inhalation Solution (APT-1026) in Stable Cystic Fibrosis Patients
AudioAbstracts
Journal of Cystic Fibrosis: Efficacy and Safety of Levofloxacin Inhalation Solution (APT-1026) in Stable Cystic Fibrosis Patients
Better Air Quality Decreases Respiratory Symptoms
Better Air Quality Decreases Respiratory Symptoms
The JAMA Report™
Better Air Quality Decreases Respiratory Symptoms
New Procedure Helps Patients with Severe Emphysema
New Procedure Helps Patients with Severe Emphysema
The JAMA Report™
New Procedure Helps Patients with Severe Emphysema

1-14 of 14

Title